Drug-drug interaction discovery and demystification using Semantic Web technologies (vol 24, pg 556, 2017)

被引：0
|
作者：
Noor, Adeeb
Assiri, Abdullah
Ayvaz, Serkan
Clark, Connor
Dumontier, Michel
机构：
来源：
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION | 2019年 / 26卷 / 11期
关键词：
D O I：
10.1093/jamia/ocz061
中图分类号：
TP [自动化技术、计算机技术];
学科分类号：
0812 ;
摘要：
引用
收藏
页码：1422 / 1422
页数：1
相关论文
共 50 条
  • [21] Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need (vol 15, pg 217, 2017)
    Field, Mark C.
    Horn, David
    Fairlamb, Alan H.
    Ferguson, Michael A. J.
    Gray, David W.
    Read, Kevin D.
    De Rycker, Manu
    Torrie, Leah S.
    Wyatt, Paul G.
    Wyllie, Susan
    Gilbert, Ian H.
    NATURE REVIEWS MICROBIOLOGY, 2017, 15 (07) : 447 - 447
  • [22] Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need (vol 15, pg 217, 2017)
    Field, Mark C.
    Horn, David
    Fairlamb, Alan H.
    Ferguson, Michael A. J.
    Gray, David W.
    Read, Kevin D.
    De Rycker, Manu
    Torrie, Leah S.
    Wyatt, Paul G.
    Wyllie, Susan
    Gilbert, Ian H.
    NATURE REVIEWS MICROBIOLOGY, 2018, 16 (11) : 714 - 714
  • [23] Animal inflammation-based models of depression and their application to drug discovery (vol 12, pg 995, 2017)
    Ma, L.
    Demin, K. A.
    Kolesnikova, T. O.
    Khatsko, Sergey L.
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (11) : 1179 - 1179
  • [24] Comparison of Critical Drug-Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia (vol 87, pg 48, 2009)
    Olvey, E. L.
    Clauschee, S.
    Malone, D. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 138 - 138
  • [25] A novel computational drug repurposing approach for Systemic Lupus Erythematosus (SLE) treatment using Semantic Web technologies
    Noor, Adeeb
    Assiri, Abdullah
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (07) : 3886 - 3892
  • [26] Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling (vol 61, pg 375, 2022)
    Montanha, Maiara Camotti
    Fabrega, Francesc
    Howarth, Alice
    Cottura, Nicolas
    Kinvig, Hannah
    Bunglawala, Fazila
    Lloyd, Andrew
    Denti, Paolo
    Waitt, Catriona
    Siccardi, Marco
    CLINICAL PHARMACOKINETICS, 2022, 61 (11) : 1641 - 1641
  • [27] Building a Knowledge Base of Severe Adverse Drug Events Based on AERS Reporting Data Using Semantic Web Technologies
    Jiang, Guoqian
    Wang, Liwei
    Liu, Hongfang
    Solbrig, Harold R.
    Chute, Christopher G.
    MEDINFO 2013: PROCEEDINGS OF THE 14TH WORLD CONGRESS ON MEDICAL AND HEALTH INFORMATICS, PTS 1 AND 2, 2013, 192 : 496 - 500
  • [28] Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process
    Watanabe, Akiko
    Nakamura, Koichi
    Okudaira, Noriko
    Okazaki, Osamu
    Sudo, Ken-ichi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) : 1232 - 1238
  • [29] Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China. (vol 7, pg 24, 2009)
    Hong, Kui
    Gao, An-Hui
    Xie, Qing-Yi
    Gao, Hao
    Zhuang, Ling
    Lin, Hai-Peng
    Yu, Hai-Ping
    Li, Jia
    Yao, Xin-Sheng
    Goodfellow, Michael
    Ruan, Ji-Sheng
    MARINE DRUGS, 2009, 7 (04): : 495 - 496
  • [30] Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery (vol 7, pg 561, 2017)
    Guerrero-Zotano, Angel L.
    Arteaga, Carlos L.
    CANCER DISCOVERY, 2019, 9 (02) : 304 - 304
12345